Daily non-political popular news in brief.

Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids

Two years or more of oral steroid treatment decreases the risk of rheumatoid arthritis related lymphoma, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology, in Barcelona, Spain. Furthermore, these effects were found regardless of when in the course of the disease the steroids were first administered. However, these beneficial effects were not observed if the steroids were taken for less than a two-year period.

Read more »

Keywords: risk, lymphoma, rheumatoid, arthritis, decreased, long-term, treatment, steroids, arthriti, long, term, steroid

« Previous | Next »

Similar news on "Risk of lymphoma in rheumatoid arthritis decreased by long-term treatment with steroids":

1. Disability from long-term rheumatoid arthritis reduced with biologic treatment
   06-12-2007 · EurekAlert!
   New data demonstrating the safety and efficacy of Enbrel (etanercept) in the treatment of rheumatoid arthritis (RA) patients over the long-term were presented today at the EULAR (European League Against Rheumatism) congress (1). Over 2,000 patients receiving this biologic treatment for up to nine years, saw improvements in disability whilst safety was also sustained over the long-term.
   Similar news · Read more »
   
2. Common rheumatoid arthritis treatment shows potential for diabetes prevention
   07-10-2007 · EurekAlert!
   Fewer rheumatoid arthritis patients treated with the drug hydroxychloroquine went on to develop diabetes compared to those who never took the drug, according to a 20-plus-year University of Pittsburgh School of Medicine-led study reported today in the Journal of the American Medical Association. In addition, those using HCQ were less likely to take medications to manage diabetes after diagnosis. The study found risk declined a dramatic 77 percent after four years of HCQ treatment.
   Similar news · Read more »
   
3. Experimental MS drug shows promise, offers new window on disease
   02-13-2008 · EurekAlert!
   A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
   Similar news · Read more »
   
4. Increased alcohol intake associated with decreased risk of developing rheumatoid arthritis
   06-15-2007 · EurekAlert!
   New data presented today at EULAR 2007 suggest that alcohol may protect against rheumatoid arthritis, with three units a week exhibiting protective effects and ten units a week being more protective still. An alcohol consumption of three units per week or more also reduced the risk by smoking or by a genetic predisposition to RA.
   Similar news · Read more »
   
5. Biologic treatment for rheumatoid arthritis and the risk of cancer
   08-29-2007 · EurekAlert!
   Findings of various clinical trials and observational studies conflict over the risk of malignancy related to the use of tumor necrosis factor alpha blockers.
   Similar news · Read more »
   
6. Predicting the risk of rheumatoid arthritis for early arthritis patients
   01-30-2007 · EurekAlert!
   A wealth of research supports early aggressive treatment with disease-modifying antirheumatic drugs (DMARDs) as the best course for preventing joint damage and avoiding the fate of a wheelchair. Still, the use of DMARDs, even the widely prescribed and generally safe methotrexate, brings the risk of liver damage and other serious complications.
   Similar news · Read more »
   
7. Longer term breast feeding protects mother from risk of developing rheumatoid arthritis
   06-15-2007 · EurekAlert!
   Breast feeding for a period of 13 months or more has been shown to reduce the mother's the risk of developing rheumatoid arthritis, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. In the study, the longer the breast feeding period, the lower the mother's risk of developing RA in later life. Comparable use of oral contraceptives or hormone replacement therapy did not show a significant effect on the risk of developing RA.
   Similar news · Read more »
   
8. The link between rheumatoid arthritis and cancer
   02-27-2007 · EurekAlert!
   The first study to investigate whether patients with RA who develop cancer have a decreased rate of survival, featured in the March 2007 issue of Arthritis & Rheumatism, also examined the impact of rheumatic disease on overall cancer incidence.
   Similar news · Read more »
   
9. Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis
   06-13-2007 · EurekAlert!
   Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced the presentation of additional data that showed that the safety profile of Enbrel was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis who completed up to eight years of therapy. The study results will be presented at the European League Against Rheumatism Annual Congress, an international rheumatology meeting, in Barcelona, Spain.
   Similar news · Read more »
   
10. TNF-alpha antagonist stops inflammation-induced colon cancer in its tracks
    01-24-2008 · EurekAlert!
    Individuals with the inflammatory bowel disease ulcerative colitis are at increased risk of developing colon cancer. New data have identified a central role for the soluble factor TNF-alpha in the development of colon cancer in mice induced to have inflammatory bowel disease. These data provide clear rationale for the idea that drugs antagonizing TNF-alpha (such as those used to treat rheumatoid arthritis) might reduce the risk of colon cancer in individuals with UC.
    Similar news · Read more »